Potential Role of the Mitochondria for the Dermatological Treatment of Papillon-Lefèvre
Metadatos
Mostrar el registro completo del ítemEditorial
Mdpi
Materia
Papillon–Lefèvre syndrome 1 Mitochondria 2; coenzyme Q10 3
Fecha
2021-01-12Referencia bibliográfica
Castejón-Vega, B.; Battino, M.; Quiles, J.L.; Bullon, B.; Cordero, M.D.; Bullón, P. Potential Role of the Mitochondria for the Dermatological Treatment of Papillon-Lefèvre. Antioxidants 2021, 10, 95. [https://doi.org/10.3390/antiox10010095]
Patrocinador
Andalusian regional government (Grupo de Investigación Junta de Andalucía) CTS113Resumen
The Papillon–Lefèvre syndrome (PLS) is a rare autosomal recessive disorder caused by
mutations in the Cathepsin C (CTSC) gene, characterized by periodontitis and palmoplantar hyperkeratosis.
The main inflammatory deficiencies include oxidative stress and autophagic dysfunction.
Mitochondria are the main source of reactive oxygen species; their impaired function is related to skin
diseases and periodontitis. The mitochondrial function has been evaluated in PLS and mitochondria
have been targeted as a possible treatment for PLS. We show for the first time an important mitochondrial
dysfunction associated with increased oxidative damage of mtDNA, reduced CoQ10 and
mitochondrial mass and aberrant morphologies of the mitochondria in PLS patients. Mitochondrial
dysfunction, determined by oxygen consumption rate (OCR) in PLS fibroblasts, was treated with
CoQ10 supplementation, which determined an improvement in OCR and a remission of skin damage
in a patient receiving a topical administration of a cream enriched with CoQ10 0.1%. We provide the
first evidence of the role of mitochondrial dysfunction and CoQ10 deficiency in the pathophysiology
of PLS and a future therapeutic option for PLS.